In recent trading session, Microbot Medical Inc (NASDAQ:MBOT) saw 0.74 million shares changing hands at last check today with its beta currently measuring 1.51. Company’s recent per share price level of $1.74 trading at -$0.06 or -3.61% at last check today assigns it a market valuation of $48.64M. That most recent trading price of MBOT’s stock is at a discount of -94.25% from its 52-week high price of $3.38 and is indicating a premium of 52.87% from its 52-week low price of $0.82. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.96 million shares which gives us an average trading volume of 2.86 million if we extend that period to 3-months.
For Microbot Medical Inc (MBOT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.18 in the current quarter.
Microbot Medical Inc (NASDAQ:MBOT) trade information
Upright in the red during last session for losing -3.61%, in the last five days MBOT remained trading in the red while hitting it’s week-highest on Friday, 01/24/25 when the stock touched $1.74 price level, adding 23.35% to its value on the day. Microbot Medical Inc’s shares saw a change of 54.91% in year-to-date performance and have moved -9.16% in past 5-day. Microbot Medical Inc (NASDAQ:MBOT) showed a performance of 56.31% in past 30-days. Number of shares sold short was 0.57 million shares which calculate 2.65 days to cover the short interests.
Microbot Medical Inc (MBOT) estimates and forecasts
Statistics highlight that Microbot Medical Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 73.50% of value to its shares in past 6 months, showing an annual growth rate of 32.38% while that of industry is 14.40. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 15.28% during past 5 years.
Microbot Medical Inc (NASDAQ:MBOT)’s Major holders
Insiders are in possession of 1.43% of company’s total shares while institution are holding 7.46 percent of that, with stock having share float percentage of 7.57%. Investors also watch the number of corporate investors in a company very closely, which is 7.46% institutions for Microbot Medical Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at MBOT for having 0.46 million shares of worth $0.47 million. And as of 2024-06-30, it was holding 3.2694 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 0.14 million shares on 2024-06-30. The number of shares represents firm’s hold over 0.9773 of outstanding shares, having a total worth of $0.14 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024, the former fund manager was holding 348.55 shares of worth $0.61 million or 1.72% of the total outstanding shares. The later fund manager was in possession of 108.03 shares on Sep 30, 2024, making its stake of worth around $0.19 million in the company or a holder of 0.53% of company’s stock.
